| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
sex determining region Y | 0.456 | 0.808 |
|
disease | 0.100 | None | 0 | 0 | ||||||||||||
|
RNA binding motif protein 5 | 0.674 | 0.346 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
regulator of chromosome condensation 1 | 0.686 | 0.538 | 0.93 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
GPC3 antisense RNA 1 | 0.861 | 0.115 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | |||||||||
|
transmembrane protein 132D | 0.617 | 0.692 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2006 | 2006 | ||||||||
|
C-C motif chemokine receptor 6 | 0.485 | 0.808 | 5.8E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
Kruppel like factor 6 | 0.501 | 0.846 | 0.98 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
phosphatidylinositol-4-phosphate 5-kinase like 1 | 0.821 | 0.115 | 2.9E-05 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
allograft inflammatory factor 1 | 0.521 | 0.808 | 1.9E-06 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
epoxide hydrolase 1 | 0.500 | 0.846 | 3.2E-09 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2004 | 2004 | ||||||||
|
epidermal growth factor receptor pathway substrate 8 | 0.608 | 0.615 | 0.97 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2016 | 2016 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 | ||||||||
|
FA complementation group C | 0.507 | 0.808 | 2.8E-13 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 | ||||||||
|
H19 imprinted maternally expressed transcript | 0.494 | 0.923 |
|
disease | 0.010 | None | < 0.001 | 1 | 3 | 2019 | 2019 | |||||||||
|
inhibitor of DNA binding 1, HLH protein | 0.544 | 0.692 | 3.1E-04 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
mutS homolog 2 | 0.406 | 0.808 | 0.90 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2007 | 2007 | ||||||||
|
nicotinamide N-methyltransferase | 0.559 | 0.654 | 5.3E-08 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
FA complementation group L | 0.551 | 0.731 | 5.9E-23 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 | ||||||||
|
golgi phosphoprotein 3 like | 0.736 | 0.231 | 1.3E-05 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2001 | 2001 | ||||||||
|
sodium voltage-gated channel alpha subunit 8 | 0.510 | 0.731 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
long intergenic non-protein coding RNA 2604 | 0.805 | 0.077 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | |||||||||
|
signal transducer and activator of transcription 2 | 0.569 | 0.615 | 0.93 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
trefoil factor 3 | 0.518 | 0.885 | 1.6E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
DNL-type zinc finger | 0.663 | 0.538 | 2.5E-04 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2001 | 2001 |